21-day wear time
Three weeks of uninterrupted monitoring reduces sensor changes and lowers the practical burden of diabetes management.
Medical Devices / Diabetes
21-day continuous glucose monitoring for daily diabetes management, clinical follow-up, and connected care.
Product Overview
The system continuously tracks glucose trends and sends readings to a smartphone every 5 minutes. It helps users understand daily glucose changes and gives healthcare providers richer data for follow-up decisions.
Key Advantages
Three weeks of uninterrupted monitoring reduces sensor changes and lowers the practical burden of diabetes management.
Users can receive the first glucose reading in just 15 minutes after sensor insertion, supporting faster response to glucose changes.
The brochure reports 8.2% MARD, 100% of glucose readings in Consensus A+B Zones, and 99.4% in Clarke A+B Zones.
Comfort and Daily Use
The sensor is calibration-free during the 21-day wearing period and does not require routine finger-prick calibration. The ultra-thin 4.5 mm sensor design, hypoallergenic adhesive, and IP58 waterproof grade support daily wear during ordinary activity, showering, and swimming.
Smart Connectivity
The companion app supports real-time monitoring, glucose alerts, event records, data sharing, and professional reports. Users can track glucose trends alongside meals, exercise, and medication events.
Clinical Workflow
The hospital-based blood glucose management system allows doctors to check patient glucose status, download and view professional analysis reports, and provide treatment plans.
Care teams can review glucose status and trends during follow-up.
Professional blood glucose analysis reports support structured clinical discussion.
Continuous data helps providers guide patient education and treatment adjustment conversations.
Specifications